Dronabinol or ondansetron alone and combined for delayed chemotherapy-induced nausea and vomiting (CINV).

被引：1
|
作者：
Jhangiani, H
Vredenburgh, JJ
Barbato, L
Yang, HC
Yang, HM
Baranowski, V
Tse, N
机构：
[1] Pacific Coast Hematol Oncol Med Grp Inc, Compassionate Canc Care, Fountain Valley, CA USA
[2] Duke Univ, Med Ctr, Duke Brain Tumor Ctr, Durham, NC USA
[3] Solvay Pharmaceut Inc, Neurosci, Marietta, GA USA
[4] Solvay Pharmaceut Inc, Clin Dev & Med Affairs, Marietta, GA USA
[5] Quintiles Inc, Med Serv, San Francisco, CA USA
[6] Quintiles Inc, Sci Serv, San Francisco, CA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.5555.5555
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5555
引用
收藏
页码：477B / 477B
页数：1
相关论文
共 50 条
  • [21] Analysis of phase III clinical studies for palonosetron, ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
    Barbour, S. Y.
    Morrow, G. R.
    Ahmed, R.
    Ballinari, G.
    Thorn, M. D.
    Cox, D.
    Schwartzberg, L. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Delayed Chemotherapy-Induced Nausea and Vomiting in Children with Cancer
    Demirkaya, Metin
    Sevinir, Betul
    Demiral, Meliha
    Ozdemir, Ramazan
    GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2011, 9 (01): : 1 - 6
  • [23] Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
    Gao, Ai
    Guan, Shasha
    Sun, Yinjuan
    Wang, Lingling
    Meng, Fanlu
    Liu, Xia
    Gu, Liyan
    Li, Guo
    Zhong, Diansheng
    Zhang, Linlin
    BMC CANCER, 2023, 23 (01)
  • [24] Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
    Ai Gao
    Shasha Guan
    Yinjuan Sun
    Lingling Wang
    Fanlu Meng
    Xia Liu
    Liyan Gu
    Guo Li
    Diansheng Zhong
    Linlin Zhang
    BMC Cancer, 23
  • [25] ONDANSETRON VERSUS METOCLOPRAMIDE IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - A METAANALYSIS
    RUSTHOVEN, J
    OBRIEN, BJ
    ROCCHI, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (04) : 443 - 450
  • [26] Olanzapine for the Prophylaxis and Rescue of Chemotherapy-Induced Nausea and Vomiting (CINV): A Retrospective Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (08) : 11 - 12
  • [27] Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
    Jordan, K.
    Jahn, F.
    Aapro, M.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1081 - 1090
  • [28] Rolapitant for Control of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients With Lung Cancer
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (08) : 8 - 9
  • [29] Development of Transdermal Ondansetron Hydrochloride for the Treatment of Chemotherapy-Induced Nausea and Vomiting
    Rajabalaya, Rajan
    Chen, Ding Siok
    David, Sheba Rani Nakka
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (03) : 279 - 285
  • [30] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - REPLY
    GEBBIA, V
    CANNATA, G
    GEBBIA, N
    CANCER, 1995, 76 (03) : 536 - 536
12345